Brief: Nabriva Therapeutics Announces Retirement Of Its Chief Financial Officer
01/02/2021 23:22
Feb 1 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* NABRIVA THERAPEUTICS ANNOUNCES RETIREMENT OF ITS CHIEF
FINANCIAL
OFFICER
* NABRIVA THERAPEUTICS - RETIREMENT OF GARY SENDER AS CHIEF
FINANCIAL OFFICER, EFFECTIVE AS OF MARCH 12
* NABRIVA THERAPEUTICS - SENDER AGREED TO SERVE AS A
CONSULTANT
FOR NABRIVA ON ONGOING BASIS FOLLOWING RETIREMENT
* NABRIVA THERAPEUTICS PLC - SEARCH HAS BEEN INITIATED TO
IDENTIFY
A NEW CFO
Source text for Eikon: ID:nGNX7Bq5cP
Further company coverage: NBRV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update